Dry eye disease in patients with metabolic syndrome

References

1. ↵
   1. Bron AJ,
   2. Smith JA,
   3. Calonge M,
   4. Methodologies to diagnose and monitor dry eye disease

   (2007) 2007 report of the international Dry Eye workshop (DEWS). Diagnostic methodology subcommittee of the international Dry Eye Work Shop. Ocul Surf 5:108–123.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Bhavsar AS,
   2. Bhavsar SG,
   3. Jain SM

   (2011) A review on recent advances in dry eye: Pathogenesis and management. Oman J Ophthalmol 4:50–56.

   OpenUrlPubMed
3. ↵
   1. Versura P,
   2. Giannaccare G,
   3. Campos EC

   (2015) Sex-steroid imbalance in females and dry eye. Curr Eye Res 40:162–175.

   OpenUrl
4. ↵
   1. Lin H,
   2. Yiu SC

   (2014) Dry eye disease: A review of diagnostic approaches and treatments. Saudi J Ophthalmol 28:173–181.

   OpenUrl
5. ↵
   1. Behrens A,
   2. Doyle JJ,
   3. Stern L,
   4. Chuck RS,
   5. McDonnell PJ,
   6. Azar DT,
   7. et al.

   (2006) Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900–907.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   (2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5:75–92.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Versura P,
   2. Campos EC

   (2013) TearLab®Osmolarity System for diagnosing dry eye. Expert Rev Mol Diagn 13:119–129.

   OpenUrlCrossRefPubMed
8. ↵
   1. Ford ES

   (2004) The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173:309–114.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Kawashima M,
   2. Uchino M,
   3. Yokoi N,
   4. Dogru M,
   5. Uchino Y,
   6. Komuro A,
   7. et al.

   (2014) Decreased tear volume in patients with metabolic syndrome: the Osaka study. Br J Ophthalmol 98:418–420.

   OpenUrlFREE Full Text
10. ↵
    1. Park HW,
    2. Park JW

    (2016) The association between symptoms of dry eye syndrome and metabolic outcome in a general population in Korea. J Korean Med Sci 31:1121–1126.

    OpenUrl
11. ↵
    1. Grundy SM,
    2. Cleeman JI,
    3. Daniels SR,
    4. Donato KA,
    5. Eckel RH,
    6. Franklin BA,
    7. et al.

    (2005) American Heart Association;National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation 112:2735–2752.

    OpenUrlFREE Full Text
12. ↵
    1. McMonnies C,
    2. Ho A,
    3. Wakefield D

    (1998) Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol 438:835–838.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Foulks GN,
    2. Lemp MA,
    3. Berg M,
    4. Bhola R,
    5. Sullivan BD

    (2009) TearLab™osmolarity as a biomarker for disease severity in mild to moderate dry eye disease. Am Acad Ophthalmol, PO382.
14. ↵
    1. Lee JH,
    2. Kee CW

    (1988) The significance of tear film break-up time in the diagnosis of dry eye syndrome. Korean J Ophthalmol 2:69–71.

    OpenUrlPubMed
15. ↵
    1. Bowling B

    (2016) Kanski’s Clinical Ophthalmology: A systematic approach (Elsevier Saunders, Philadelphia (PA)), 8th ed, p 124.
16. ↵
    1. Versura P,
    2. Profazio V,
    3. Campos EC

    (2010) Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res 35:553–564.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Sağdık HM,
    2. Ugurbas SH,
    3. Can M,
    4. Tetikoğlu M,
    5. Ugurbas E,
    6. Uğurbaş SC,
    7. et al.

    (2013) Tear film osmolarity in patients with diabetes mellitus. Ophthalmic Res 50:1–5.

    OpenUrlCrossRefPubMed
18. 1. Fuerst N,
    2. Langelier N,
    3. Massaro-Giordano M,
    4. Pistilli M,
    5. Stasi K,
    6. Burns C,
    7. et al.

    (2014) Tear osmolarity and dry eye symptoms in diabetics. Clin Ophthalmol 8:507–515.

    OpenUrlPubMed
19. ↵
    1. Najafi L,
    2. Malek M,
    3. Valojerdi AE,
    4. Aghili R,
    5. Khamseh ME,
    6. Fallah AE,
    7. et al.

    (2013) Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus. J Diabetes Complications 27:459–462.

    OpenUrlCrossRefPubMed
20. ↵
    1. Kaiserman I,
    2. Kaiserman N,
    3. Nakar S,
    4. Vinker S

    (2005) Dry eye in diabetic patients. Am J Ophthalmol 139:498–503.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Lv H,
    2. Li A,
    3. Zhang X,
    4. Xu M,
    5. Qiao Y,
    6. Zhang J,
    7. et al.

    (2014) Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients. Acta Ophthalmol 92:e96–e104.

    OpenUrl
22. ↵
    1. Tomlinson A,
    2. Bron AJ,
    3. Korb DR,
    4. Amano S,
    5. Paugh JR,
    6. Pearce EI,
    7. et al.

    (2011) The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 52:2006–2049.

    OpenUrlFREE Full Text
23. ↵
    1. Radhika G,
    2. Van Dam RM,
    3. Sudha V,
    4. Ganesan A,
    5. Mohan V

    (2009) Refined grain consumption and the metabolic syndrome in urban Asian Indians (Chennai Urban Rural Epidemiology Study 57). Metabolism 58:675–681.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. Stevenson W,
    2. Chauhan SK,
    3. Dana R

    (2012) Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol 130:90–100.

    OpenUrlCrossRefPubMedWeb of Science